HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rolf Mentlein Selected Research

CXCR4 Receptors (CXCR4 Receptor)

7/2014Effects of the chemokine CXCL12 and combined internalization of its receptors CXCR4 and CXCR7 in human MCF-7 breast cancer cells.
10/2013Expression of the chemokines CXCL12 and CX3CL1 and their receptors in human nerve sheath tumors.
3/2013An infernal trio: the chemokine CXCL12 and its receptors CXCR4 and CXCR7 in tumor biology.
5/2012CXCL12 mediates apoptosis resistance in rat C6 glioma cells.
12/2011Near-infrared molecular imaging of tumors via chemokine receptors CXCR4 and CXCR7.
4/2010The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rolf Mentlein Research Topics

Disease

25Neoplasms (Cancer)
01/2022 - 03/2002
24Glioma (Gliomas)
01/2018 - 03/2002
10Glioblastoma (Glioblastoma Multiforme)
07/2017 - 06/2005
7Neoplasm Metastasis (Metastasis)
10/2016 - 09/2003
6Astrocytoma (Pilocytic Astrocytoma)
11/2016 - 06/2005
6Meningioma (Meningiomas)
10/2016 - 03/2002
5Osteoarthritis
07/2007 - 01/2004
3Breast Neoplasms (Breast Cancer)
07/2014 - 06/2006
3Brain Neoplasms (Brain Tumor)
05/2012 - 03/2002
3Necrosis
06/2005 - 05/2003
3Hypoxia (Hypoxemia)
01/2004 - 05/2003
2Multiple Trauma (Multiple Injuries)
01/2014 - 02/2012
2Neurilemmoma (Schwannoma)
10/2013 - 05/2008
2Carcinogenesis
03/2012 - 02/2007
2Type 2 Diabetes Mellitus (MODY)
08/2009 - 01/2005
2Inflammation (Inflammations)
01/2009 - 09/2008
2Ischemia
09/2008 - 11/2002
2Rheumatoid Arthritis
11/2005 - 03/2003
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2022
1Melanoma (Melanoma, Malignant)
07/2017
1Virus Diseases (Viral Diseases)
11/2014
1Wounds and Injuries (Trauma)
01/2014
1Nerve Sheath Neoplasms (Nerve Sheath Neoplasm)
10/2013
1Pathologic Processes
03/2013
1Bacterial Infections (Bacterial Infection)
02/2012
1Gliosis
09/2008

Drug/Important Bio-Agent (IBA)

20Proteins (Proteins, Gene)FDA Link
07/2014 - 03/2002
17Messenger RNA (mRNA)IBA
11/2016 - 03/2002
12ChemokinesIBA
01/2018 - 06/2005
11Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2006 - 11/2002
7Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2018 - 11/2002
6CXCR4 Receptors (CXCR4 Receptor)IBA
07/2014 - 04/2010
5Peptide Hydrolases (Proteases)FDA Link
01/2018 - 01/2005
5Biological ProductsIBA
10/2016 - 02/2007
5Chemokine CXCL12IBA
07/2014 - 04/2010
5Chemokine ReceptorsIBA
07/2014 - 04/2010
5EnzymesIBA
03/2013 - 11/2002
4CytokinesIBA
01/2018 - 11/2003
4Transcription Factors (Transcription Factor)IBA
11/2016 - 01/2004
4Chemokine CXCL16IBA
10/2016 - 06/2005
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2013 - 03/2004
4Peptides (Polypeptides)IBA
03/2013 - 10/2002
4Matrix Metalloproteinases (MMPs)IBA
03/2010 - 03/2004
4pleiotrophin (HARP)IBA
07/2007 - 11/2002
3Chemokine CX3CL1IBA
01/2016 - 05/2010
3Temozolomide (Temodar)FDA LinkGeneric
03/2013 - 05/2012
3Pharmaceutical PreparationsIBA
12/2012 - 04/2010
3Angiogenic ProteinsIBA
06/2006 - 11/2002
2Liposomes (Liposome)IBA
01/2022 - 05/2008
2Proteoglycans (Proteoglycan)IBA
01/2018 - 01/2006
2GlycosaminoglycansIBA
01/2018 - 01/2009
2Small Interfering RNA (siRNA)IBA
10/2016 - 12/2012
2Interleukin-6 (Interleukin 6)IBA
01/2014 - 03/2004
2LigandsIBA
10/2013 - 02/2013
2CamptothecinIBA
03/2013 - 02/2007
2Metalloproteases (Metalloproteinases)IBA
04/2012 - 01/2006
2DisintegrinsIBA
04/2012 - 01/2006
2Serine Proteases (Serine Protease)IBA
04/2012 - 03/2011
2Bovine Serum AlbuminIBA
04/2011 - 03/2011
2IncretinsIBA
08/2009 - 01/2005
2Dipeptidyl-Peptidase IV InhibitorsIBA
08/2009 - 01/2005
2DNA (Deoxyribonucleic Acid)IBA
06/2008 - 11/2002
2Phosphotransferases (Kinase)IBA
05/2008 - 06/2003
2Mitogen-Activated Protein KinasesIBA
05/2008 - 03/2004
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
08/2006 - 11/2002
2Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
06/2005 - 03/2004
2Insulin (Novolin)FDA Link
01/2005 - 10/2002
2ThymidineIBA
03/2004 - 11/2002
2ImmunosorbentsIBA
03/2004 - 05/2003
2Platelet-Derived Growth FactorIBA
11/2003 - 05/2003
1IronIBA
01/2022
1Immunoglobulin Fab FragmentsIBA
01/2022
1IntegrinsIBA
01/2018
1Carrier Proteins (Binding Protein)IBA
01/2018
1Glycoproteins (Glycoprotein)IBA
01/2018
1Glycoside Hydrolases (Endoglycosidases)IBA
01/2018
1MicroRNAs (MicroRNA)IBA
01/2018
1CXC ChemokinesIBA
07/2017
1Antimicrobial PeptidesIBA
01/2014
1Muramidase (Lysozyme)IBA
01/2014
1Effector CaspasesIBA
03/2013
1CaspasesIBA
03/2013
1Forkhead Transcription Factors (Forkhead Box Proteins)IBA
03/2013
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
03/2013
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
03/2013
1Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA
12/2012
1Caspase 8 (Caspase-8)IBA
12/2012
1Pertussis ToxinIBA
03/2012
1Fluorescent Dyes (Fluorescent Probes)IBA
12/2011
1fibroblast activation protein alphaIBA
03/2011
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
04/2010
1Aggrecans (Aggrecan)IBA
01/2009
1MethyltransferasesIBA
06/2008
1A-Form DNA (A-DNA)IBA
06/2008
1O-(6)-methylguanineIBA
06/2008
1ferric oxide (iron oxide)IBA
05/2008
1U 0126 (UO 126)IBA
05/2008

Therapy/Procedure

5Therapeutics
10/2013 - 09/2003
1Aftercare (After-Treatment)
12/2012
1Lasers (Laser)
05/2008